BioCryst Downgraded By JPMorgan, Analysts Await 'More Data'
February 09, 2016 at 08:51 AM EST
The share price of BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) has plunged 82.53 percent over the past one year, reaching ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.